1. Home
  2. Analysis
  3. Fingolimod
  4. Leukopenia

Fingolimod and Leukopenia - a phase IV clinical study of FDA data

Summary:

Leukopenia is reported as a side effect among people who take Fingolimod (fingolimod), especially for people who are male, 40-49 old, have been taking the drug for 6 - 12 months also take Gilenya, and have Relapsing-remitting multiple sclerosis.

The phase IV clinical study analyzes which people have Leukopenia when taking Fingolimod. It is created by eHealthMe based on reports of 5,142 people who have side effects when taking Fingolimod from the FDA, and is updated regularly.

What is Fingolimod?

Fingolimod has active ingredients of fingolimod. eHealthMe is studying from 5,150 Fingolimod users. Check the latest studies of Fingolimod.

What is Leukopenia?

Leukopenia (less number of white blood cells in blood) is found to be associated with 1,684 drugs and 2,290 conditions by eHealthMe. Check the latest studies of Leukopenia.

On Jul, 28, 2026

5,142 people reported to have side effects when taking Fingolimod.
Among them, 60 people (1.17%) have Leukopenia.

Could Fingolimod cause Leukopenia?

Among these 60 people:

How long have people been on Fingolimod when they have Leukopenia? *

  • < 1 month: 6.67 %
  • 1 - 6 months: 13.33 %
  • 6 - 12 months: 60.0 %
  • 1 - 2 years: 6.67 %
  • 2 - 5 years: 13.33 %
  • 5 - 10 years: 0.0 %
  • 10+ years: 0.0 %

What is the gender of people who have Leukopenia when taking Fingolimod? *

  • female: 48.21 %
  • male: 51.79 %

What is the age of people who have Leukopenia when taking Fingolimod? *

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 2.22 %
  • 30-39: 24.44 %
  • 40-49: 60.0 %
  • 50-59: 8.89 %
  • 60+: 4.44 %

What are other drugs people take besides Fingolimod? *

  1. Gilenya: 4 people, 6.67%
  2. Vitamin D: 2 people, 3.33%
  3. Omeprazole: 2 people, 3.33%
  4. Kesimpta: 2 people, 3.33%
  5. Temozolomide: 2 people, 3.33%
  6. Prednisone: 1 person, 1.67%
  7. Cyanocobalamin: 1 person, 1.67%
  8. Atarax: 1 person, 1.67%
  9. Azathioprine: 1 person, 1.67%
  10. Azelaic Acid: 1 person, 1.67%

What are other side effects people have besides Leukopenia? *

  1. Lymphopenia (an abnormally low level of lymphocytes in the blood): 31 people, 51.67%
  2. Haematuria (presence of blood in urine): 18 people, 30.00%
  3. Gastrointestinal Haemorrhage (bleeding gastrointestinal tract): 18 people, 30.00%
  4. Urinary Retention (the inability to completely or partially empty the bladder): 18 people, 30.00%
  5. Hyperbilirubinaemia (excess of bilirubin in the blood): 18 people, 30.00%
  6. Proctitis (inflammation of the rectum and anus): 18 people, 30.00%
  7. Cellulitis (infection under the skin): 14 people, 23.33%
  8. Lymphocyte Count Decreased: 9 people, 15.00%
  9. Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection): 7 people, 11.67%
  10. Thrombocytopenia (decrease of platelets in blood): 5 people, 8.33%

What are the existing conditions these people have? *

  1. Relapsing-Remitting Multiple Sclerosis (reoccurrence of an inflammatory disease in which the insulating covers of nerve cells in the brain and spinal cord are damaged): 29 people, 48.33%
  2. Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 26 people, 43.33%
  3. Rickets (softening of bones): 2 people, 3.33%
  4. Glioblastoma (most common and most aggressive malignant primary brain tumour in humans): 2 people, 3.33%
  5. Osteoporosis (bones weak and more likely to break): 2 people, 3.33%
  6. Multiple Sclerosis Relapse (reoccurrence of a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 2 people, 3.33%
  7. Tonsillitis (inflammation of tonsil): 1 person, 1.67%
  8. Anaphylaxis (serious allergic reaction that is rapid in onset and may cause death): 1 person, 1.67%
  9. Encephalitis (inflammation of the brain): 1 person, 1.67%
  10. Hypovitaminosis (any of several diseases caused by deficiency of one or more vitamins): 1 person, 1.67%

* Approximation only. Some reports may have incomplete information.

Do you take Fingolimod and have Leukopenia?

- Check whether Leukopenia is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Fingolimod:

Leukopenia treatments and more:

How severe was Leukopenia and when was it recovered:

Expand to all the drugs that have ingredients of fingolimod:

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Fingolimod:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Leukopenia:

Browse all the conditions that are associated with Leukopenia:

Related publications that referenced our studies

How the study uses the data?

The study uses data from the FDA. It is based on fingolimod (the active ingredients of Fingolimod) and Fingolimod (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2026 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.